GB9800750D0 - Pharmaceutical compound - Google Patents
Pharmaceutical compoundInfo
- Publication number
- GB9800750D0 GB9800750D0 GBGB9800750.3A GB9800750A GB9800750D0 GB 9800750 D0 GB9800750 D0 GB 9800750D0 GB 9800750 A GB9800750 A GB 9800750A GB 9800750 D0 GB9800750 D0 GB 9800750D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical compound
- pharmaceutical
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9800750.3A GB9800750D0 (en) | 1998-01-14 | 1998-01-14 | Pharmaceutical compound |
| JP2000540115A JP2002509135A (ja) | 1998-01-14 | 1999-01-13 | 神経細胞カルシウムチャンネルの活性の調節剤としてのアミノスルホニルベンズアミド誘導体 |
| CA002317536A CA2317536A1 (fr) | 1998-01-14 | 1999-01-13 | Derives aminosulphonylbenzamides utilises comme inhibiteurs de l'activite des canaux calcium neuronaux |
| AU21728/99A AU2172899A (en) | 1998-01-14 | 1999-01-13 | Aminosulphonylbenzamide derivatives as modulators of the activity of neuronal calcium channels |
| EP99901722A EP1047670A1 (fr) | 1998-01-14 | 1999-01-13 | Derives aminosulphonylbenzamides utilises comme inhibiteurs de l'activite des canaux calcium neuronaux |
| PCT/GB1999/000099 WO1999036398A1 (fr) | 1998-01-14 | 1999-01-13 | Derives aminosulphonylbenzamides utilises comme inhibiteurs de l'activite des canaux calcium neuronaux |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9800750.3A GB9800750D0 (en) | 1998-01-14 | 1998-01-14 | Pharmaceutical compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9800750D0 true GB9800750D0 (en) | 1998-03-11 |
Family
ID=10825269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9800750.3A Ceased GB9800750D0 (en) | 1998-01-14 | 1998-01-14 | Pharmaceutical compound |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1047670A1 (fr) |
| JP (1) | JP2002509135A (fr) |
| AU (1) | AU2172899A (fr) |
| CA (1) | CA2317536A1 (fr) |
| GB (1) | GB9800750D0 (fr) |
| WO (1) | WO1999036398A1 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2812198B1 (fr) * | 2000-07-28 | 2008-07-18 | Sod Conseils Rech Applic | DERIVES D'AMIDINES INHIBITEURS DE PHOSPHATASES cdc25 |
| CA2461603A1 (fr) * | 2001-09-24 | 2003-04-03 | Elan Pharmaceuticals, Inc. | Amines substituees pour le traitement de la maladie d'alzheimer |
| TW200302717A (en) * | 2002-02-06 | 2003-08-16 | Schering Corp | Novel gamma secretase inhibitors |
| JP2006511587A (ja) | 2002-12-20 | 2006-04-06 | ミジェニックス コーポレイション | アデニンヌクレオチドトランスロカーゼ(ant)リガンドならびにそれに関連する組成物および方法 |
| CA2611731A1 (fr) * | 2005-06-09 | 2006-12-14 | Vertex Pharmaceuticals Incorporated | Derives d'indane comme modulateurs de canaux ioniques |
| JP5361857B2 (ja) * | 2007-03-23 | 2013-12-04 | ファイザー・リミテッド | イオンチャネルの阻害剤 |
| GB201007791D0 (en) * | 2010-05-10 | 2010-06-23 | Glaxo Group Ltd | Novel compounds |
| GB201007789D0 (en) * | 2010-05-10 | 2010-06-23 | Glaxo Group Ltd | Novel Compound |
| EP2726459B1 (fr) * | 2011-07-01 | 2019-09-11 | Baruch S. Blumberg Institute | Dérivés de sulfamoylbenzamide en tant qu'agents antiviraux contre une infection par vhb |
| JP7395480B2 (ja) | 2018-01-10 | 2023-12-11 | クラ セラピューティクス, エルエルシー | フェニルスルホンアミドを含む薬学的組成物、及びそれらの治療的適用 |
| US20220274921A1 (en) * | 2019-07-11 | 2022-09-01 | Cura Therapeutics, Llc | Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications |
| EP4172149A4 (fr) * | 2020-06-29 | 2024-09-04 | Bacainn Biotherapeutics, Ltd. | Composés de probénécide pour le traitement d'une maladie pulmonaire à médiation par inflammasomes |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59305042D1 (de) * | 1992-09-22 | 1997-02-20 | Hoechst Ag | Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika |
-
1998
- 1998-01-14 GB GBGB9800750.3A patent/GB9800750D0/en not_active Ceased
-
1999
- 1999-01-13 JP JP2000540115A patent/JP2002509135A/ja active Pending
- 1999-01-13 AU AU21728/99A patent/AU2172899A/en not_active Abandoned
- 1999-01-13 CA CA002317536A patent/CA2317536A1/fr not_active Abandoned
- 1999-01-13 WO PCT/GB1999/000099 patent/WO1999036398A1/fr not_active Ceased
- 1999-01-13 EP EP99901722A patent/EP1047670A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2317536A1 (fr) | 1999-07-22 |
| AU2172899A (en) | 1999-08-02 |
| JP2002509135A (ja) | 2002-03-26 |
| WO1999036398A1 (fr) | 1999-07-22 |
| EP1047670A1 (fr) | 2000-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9817118D0 (en) | Pharmaceutical compounds | |
| GB9817623D0 (en) | Pharmaceutical compounds | |
| CZ20011518A3 (cs) | Farmaceutický prostředek | |
| GB9810886D0 (en) | Pharmaceutical compounds | |
| GB9700504D0 (en) | Pharmaceutical compounds | |
| PT1466615E (pt) | Composição farmacêutica | |
| EG22250A (en) | Novel pharmaceutical compound | |
| PL343769A1 (en) | Pharmaceutical composition | |
| GB9812038D0 (en) | Therapeutic compound | |
| EP1145714A4 (fr) | Medicaments | |
| GB9818591D0 (en) | Pharmaceutical composition | |
| GB9716244D0 (en) | Pharmaceutical compounds | |
| EP1003495A4 (fr) | Composes pharmaceutiques | |
| IL145632A0 (en) | Pharmaceutical compounds | |
| GB9805348D0 (en) | Compound | |
| GB9800750D0 (en) | Pharmaceutical compound | |
| GB9916434D0 (en) | Pharmaceutical compounds | |
| GB9808268D0 (en) | Compound | |
| GB9914255D0 (en) | Pharmaceutical compounds | |
| GB9823847D0 (en) | Pharmaceutical compounds | |
| GB9823845D0 (en) | Pharmaceutical compounds | |
| GB9903784D0 (en) | Pharmaceutical compounds | |
| AP2000001878A0 (en) | Pharmaceutical compositions | |
| GB9700895D0 (en) | Pharmaceutical compounds | |
| GB2373499B (en) | Pharmaceutical compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |